Gossamer Bio Inc GOSS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:49 AM EDT
0.7501quote price arrow up+0.0173 (+2.3608%)
Volume
596,991
52 week range
0.45 - 1.88
Loading...
  • Open0.749
  • Day High0.7603
  • Day Low0.7141
  • Prev Close0.7328
  • 52 Week High1.88
  • 52 Week High Date07/20/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23

Key Stats

  • Market Cap169.687M
  • Shares Out226.22M
  • 10 Day Average Volume2.81M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-17.14

KEY STATS

  • Open0.749
  • Day High0.7603
  • Day Low0.7141
  • Prev Close0.7328
  • 52 Week High1.88
  • 52 Week High Date07/20/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23
  • Market Cap169.687M
  • Shares Out226.22M
  • 10 Day Average Volume2.81M
  • Dividend-
  • Dividend Yield-
  • Beta1.95
  • YTD % Change-17.14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.05
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-3.14
  • EBITDA (TTM)-166.261M
  • ROE (TTM)-480.50%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)772.43%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gossamer Bio Inc

 

Profile

MORE
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH). Its product candidate Seralutinib, also known as GB002, is an investigational inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT inhibitor, being evaluated in a Phase III clinical trial for the...
Faheem Hasnain
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Bryan Giraudo
Chief Financial Officer, Chief Operating Officer
Caryn Peterson
Executive Vice President - Regulatory Affairs
Christian Waage
Executive Vice President - Technical Operations and Administration
Address
3013 Science Park Rd
San Diego, CA
92121-1101
United States

Top Peers

SYMBOLLASTCHG%CHG
PROK
ProKidney Corp
4.09-0.03-0.73%
XFOR
X4 Pharmaceuticals Inc
0.9694-0.016-1.6237%
GLSI
Greenwich Lifesciences Inc
14.00+0.36+2.64%
ACHV
Achieve Life Sciences Inc
5.13+0.12+2.40%
ELEV
Elevation Oncology Inc
3.79+0.23+6.46%